249 related articles for article (PubMed ID: 21232118)
1. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.
Haque I; Mehta S; Majumder M; Dhar K; De A; McGregor D; Van Veldhuizen PJ; Banerjee SK; Banerjee S
Mol Cancer; 2011 Jan; 10():8. PubMed ID: 21232118
[TBL] [Abstract][Full Text] [Related]
2. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
3. The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.
Haque I; De A; Majumder M; Mehta S; McGregor D; Banerjee SK; Van Veldhuizen P; Banerjee S
J Biol Chem; 2012 Nov; 287(46):38569-79. PubMed ID: 23027863
[TBL] [Abstract][Full Text] [Related]
4. CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.
Maity G; Ghosh A; Gupta V; Haque I; Sarkar S; Das A; Dhar K; Bhavanasi S; Gunewardena SS; Von Hoff DD; Mallik S; Kambhampati S; Banerjee SK; Banerjee S
Mol Cancer Ther; 2019 Apr; 18(4):788-800. PubMed ID: 30787177
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
6. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
8. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
[TBL] [Abstract][Full Text] [Related]
9. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
10. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.
Wang X; Deng Y; Mao Z; Ma X; Fan X; Cui L; Qu J; Xie D; Zhang J
Tumour Biol; 2012 Oct; 33(5):1745-58. PubMed ID: 22752926
[TBL] [Abstract][Full Text] [Related]
11. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer.
Shi W; Zhang C; Chen Z; Chen H; Liu L; Meng Z
Oncotarget; 2016 Nov; 7(45):73160-73170. PubMed ID: 27705906
[TBL] [Abstract][Full Text] [Related]
12. The CCN1 (CYR61) protein promotes skin growth by enhancing epithelial-mesenchymal transition during skin expansion.
Zhou Y; Li H; Liang X; Du H; Suo Y; Chen H; Liu W; Duan R; Huang X; Li Q
J Cell Mol Med; 2020 Jan; 24(2):1460-1473. PubMed ID: 31828970
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization.
Maity G; Mehta S; Haque I; Dhar K; Sarkar S; Banerjee SK; Banerjee S
Sci Rep; 2014 May; 4():4995. PubMed ID: 24833309
[TBL] [Abstract][Full Text] [Related]
14. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
[TBL] [Abstract][Full Text] [Related]
15. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
17. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
18. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
[TBL] [Abstract][Full Text] [Related]
19. Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.
Thomas D; Sagar S; Caffrey T; Grandgenett PM; Radhakrishnan P
J Cell Mol Med; 2019 Oct; 23(10):6885-6896. PubMed ID: 31389667
[TBL] [Abstract][Full Text] [Related]
20. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
